SK Hynix Surpasses 1 Trillion Market Cap as AI Demand Boosts East Asian Equities SpaceX IPO Could Offer Significant Gains for Early Investors Microsofts Trusted Technology Lead Jenny LayFlurrie on Balancing AI Speed with Responsible Development Walmarts Cautious Sales Outlook Rattles Investor Sentiment Metas Forum App Sends Reddit Shares Sliding Nearly 6 Vincent Bollors Media Influence Sparks Calls for EU Democracy Fund QRHC Q1 2026 Earnings EPS Miss Highlights Operational Headwinds and Cost Pressures OneSpan Q1 2026 Earnings EPS Beat Drives 234 Stock Gain Amid Solid Execution ALNY Q1 2026 Earnings EPS Smashes Estimates While Shares Edge Lower Scilex Holding SCLX Q1 2026 Earnings Reported EPS of 476 Stock Rises Over 6 Amid No Revenue AMPY Q1 2026 Earnings Significant EPS Miss Highlights Operational Challenges OTIS Q1 2026 Earnings EPS Misses Estimates by 185 as Market Digests Mixed Signals GAVA Stakes Claim Near Resistance Avalanche ETF Climbs 122 Amid Volume Shift Blaize Holdings Warrants BZAIW Surge Over 19 Key Levels in Focus VeriSign Inc VRSN Edges Higher as Shares Test Key Levels Near 310 Everspin Technologies MRAM Surges 379 Amid Strong Momentum Key Levels to Watch Herzfeld Credit Income Fund HERZ Holds Steady at 1843 as RangeBound Trading Persists MLI Q1 2026 Earnings EPS Surges Past Estimates by 238 as Strong Execution Drives Results Precigen Q1 2026 Earnings Narrowed Loss Exceeds Expectations as Stock Rises UHAL Q1 2026 Earnings Significant EPS Miss Despite Modest Stock Gain HCTI Q4 2025 Earnings Staggering EPS Miss Driven by Deepening Losses GSK Q1 2026 Earnings Solid EPS Beat Amid Mixed Market Sentiment Singamas Shares Slide After US DOJ Alleges CEO Teo Siong Seng Involved in PriceFixing Conspiracy GPUS Q3 2025 Earnings Losses Persist as Hyperscale Data Ramps Up Investment Flanigans Enterprises BDL Rallies 385 Technical Levels in Focus Array Digital Infrastructure Inc UZE Q1 2026 Earnings Earnings Per Share Surges Past Estimates Sound Point Meridian Capital Inc Q1 2026 Earnings Earnings Miss as EPS Falls Short of Estimates Olema Pharmaceuticals Inc OLMA Q1 2026 Earnings NarrowerThanExpected Loss Amid Ongoing Clinical Progress RZLT Q1 2026 Earnings Narrower Loss Surpasses Expectations as Clinical Pipeline Advances Beam Therapeutics BEAM Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares Zoetis ZTS Q1 2026 Earnings EPS Misses Estimates Despite Strong Stock Performance ATLCL Q1 2026 Earnings Strong EPS Beat Signals Improved Profitability